ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,496 | -39.5% | 17,272 | -22.4% | 0.00% | – |
| Q2 2023 | $172,800 | +561.8% | 22,268 | +402.3% | 0.00% | – |
| Q4 2022 | $26,110 | – | 4,433 | +3233.1% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 133 | -94.0% | 0.00% | – |
| Q2 2022 | $10,000 | -98.9% | 2,204 | -96.5% | 0.00% | – |
| Q4 2021 | $917,000 | +68.6% | 62,399 | +140.1% | 0.00% | – |
| Q3 2021 | $544,000 | +325.0% | 25,986 | +259.0% | 0.00% | – |
| Q2 2021 | $128,000 | -83.4% | 7,239 | -77.0% | 0.00% | – |
| Q1 2021 | $772,000 | +1384.6% | 31,504 | +1963.1% | 0.00% | – |
| Q4 2020 | $52,000 | +30.0% | 1,527 | -5.2% | 0.00% | – |
| Q3 2020 | $40,000 | -58.3% | 1,610 | -43.4% | 0.00% | – |
| Q2 2020 | $96,000 | – | 2,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |